Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KONCERT: Once vs Twice Daily Kaletra in HIV-1 Children
NCT01196195Phase 3Completed
- Sponsor
- Penta Foundation
- Start
- Aug 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Penta Foundation. Started Aug 2010; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01196195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196195.